Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 70

1.

Tools for the Assessment of Comorbidity Burden in Rheumatoid Arthritis.

Aslam F, Khan NA.

Front Med (Lausanne). 2018 Feb 16;5:39. doi: 10.3389/fmed.2018.00039. eCollection 2018. Review.

2.

Electronically Available Comorbid Conditions for Risk Prediction of Healthcare-Associated Clostridium difficile Infection.

Harris AD, Sbarra AN, Leekha S, Jackson SS, Johnson JK, Pineles L, Thom KA.

Infect Control Hosp Epidemiol. 2018 Mar;39(3):297-301. doi: 10.1017/ice.2018.10. Epub 2018 Feb 5.

PMID:
29397800
3.

Developing and validating a novel multisource comorbidity score from administrative data: a large population-based cohort study from Italy.

Corrao G, Rea F, Di Martino M, De Palma R, Scondotto S, Fusco D, Lallo A, Belotti LMB, Ferrante M, Pollina Addario S, Merlino L, Mancia G, Carle F.

BMJ Open. 2017 Dec 26;7(12):e019503. doi: 10.1136/bmjopen-2017-019503.

4.

Age-adjusted Charlson comorbidity index score as predictor of survival of patients with digestive system cancer who have undergone surgical resection.

Tian Y, Jian Z, Xu B, Liu H.

Oncotarget. 2017 Jun 7;8(45):79453-79461. doi: 10.18632/oncotarget.18401. eCollection 2017 Oct 3.

5.

Physical activity and the risk of hip fracture in the elderly: a prospective cohort study.

Lagerros YT, Hantikainen E, Michaëlsson K, Ye W, Adami HO, Bellocco R.

Eur J Epidemiol. 2017 Nov;32(11):983-991. doi: 10.1007/s10654-017-0312-5. Epub 2017 Sep 22.

6.
7.

The Effect of Adding Comorbidities to Current Centers for Disease Control and Prevention Central-Line-Associated Bloodstream Infection Risk-Adjustment Methodology.

Jackson SS, Leekha S, Magder LS, Pineles L, Anderson DJ, Trick WE, Woeltje KF, Kaye KS, Stafford K, Thom K, Lowe TJ, Harris AD.

Infect Control Hosp Epidemiol. 2017 Sep;38(9):1019-1024. doi: 10.1017/ice.2017.129. Epub 2017 Jul 3.

PMID:
28669363
8.

In search of the perfect model.

Welk B.

Can Urol Assoc J. 2017 Jun;11(6):172. doi: 10.5489/cuaj.4653. No abstract available.

9.

Electronically Available Comorbidities Should Be Used in Surgical Site Infection Risk Adjustment.

Jackson SS, Leekha S, Magder LS, Pineles L, Anderson DJ, Trick WE, Woeltje KF, Kaye KS, Lowe TJ, Harris AD.

Clin Infect Dis. 2017 Sep 1;65(5):803-810. doi: 10.1093/cid/cix431.

PMID:
28481976
10.

External validation and comparison of two variants of the Elixhauser comorbidity measures for all-cause mortality.

Fortin Y, Crispo JA, Cohen D, McNair DS, Mattison DR, Krewski D.

PLoS One. 2017 Mar 28;12(3):e0174379. doi: 10.1371/journal.pone.0174379. eCollection 2017.

11.

Evaluating the effectiveness, impact and safety of live attenuated and seasonal inactivated influenza vaccination: protocol for the Seasonal Influenza Vaccination Effectiveness II (SIVE II) study.

Simpson CR, Lone NI, Kavanagh K, Robertson C, McMenamin J, von Wissmann B, Vasileiou E, Butler C, Ritchie LD, Gunson R, Schwarze J, Sheikh A.

BMJ Open. 2017 Feb 28;7(2):e014200. doi: 10.1136/bmjopen-2016-014200.

12.

Pharmacogenetic polymorphism as an independent risk factor for frequent hospitalizations in older adults with polypharmacy: a pilot study.

Finkelstein J, Friedman C, Hripcsak G, Cabrera M.

Pharmgenomics Pers Med. 2016 Oct 14;9:107-116. eCollection 2016.

13.

Fatigue in Older Adults Postmyocardial Infarction.

Crane PB, Efird JT, Abel WM.

Front Public Health. 2016 Apr 11;4:55. doi: 10.3389/fpubh.2016.00055. eCollection 2016.

15.

Comorbidity as an independent prognostic factor in elderly patients with peripheral T-cell lymphoma.

Zhao H, Wang T, Wang Y, Yu Y, Wang X, Zhao Z, Yang H, Yan B, Wu X, Da W, Zhang Y.

Onco Targets Ther. 2016 Mar 24;9:1795-9. doi: 10.2147/OTT.S93687. eCollection 2016.

16.

A population-based analysis of use and outcomes of laparoscopic bariatric surgery across socioeconomic groups in Taiwan.

Huang CC, Huang YT, Chiu CC.

Int J Equity Health. 2015 Nov 11;14:127. doi: 10.1186/s12939-015-0265-9.

17.

A Taiwanese Nationwide Cohort Study Shows Interferon-Based Therapy for Chronic Hepatitis C Reduces the Risk of Chronic Kidney Disease.

Chen YC, Hwang SJ, Li CY, Wu CP, Lin LC.

Medicine (Baltimore). 2015 Aug;94(32):e1334. doi: 10.1097/MD.0000000000001334.

18.

13-year nationwide cohort study of chronic kidney disease risk among treatment-naïve patients with chronic hepatitis B in Taiwan.

Chen YC, Su YC, Li CY, Hung SK.

BMC Nephrol. 2015 Jul 22;16:110. doi: 10.1186/s12882-015-0106-5.

19.

The Effects of Opioid Substitution Treatment and Highly Active Antiretroviral Therapy on the Cause-Specific Risk of Mortality Among HIV-Positive People Who Inject Drugs.

Nosyk B, Min JE, Evans E, Li L, Liu L, Lima VD, Wood E, Montaner JS.

Clin Infect Dis. 2015 Oct 1;61(7):1157-65. doi: 10.1093/cid/civ476. Epub 2015 Jun 25.

Supplemental Content

Support Center